Therapeutic Innovation Australia is a national consortium of translational research infrastructure.
Through TIA, Australian researchers from the public and private sector can access a range of expertise and services to assist in the development of new therapeutic products.
The TIA Consortium includes national and international expertise in the development of small molecule pharmaceuticals, biologics & vaccines and cell & gene therapies.
NCRIS responds to COVID-19
NCRIS capabilities are a collaborative network of national research infrastructure that are ready to respond to active and emerging needs. NCRIS capabilities remain open and are available to researchers working in response to COVID-19. To find out more about how NCRIS can help with your COVID-19 work, click here or to the right to download a set of fact sheets from NCRIS projects.
5 June 2020
Pipeline Accelerator 2019-20 outcomes
TIA is pleased to announce the outcomes of the Pipeline Accelerator scheme for 2019-20. A total of $560,000 has been awarded to 13 projects to support access to TIA's core facilities. Click here for more.
